Treatment of Monoclonal Gammopathy-associated C3 Glomerulopathy With Daratumumab-based Therapy

Coltoff, A., Bomback, A., Shirazian, S., Lentzsch, S., & Bhutani, D. (2021). Treatment of Monoclonal Gammopathy-associated C3 Glomerulopathy With Daratumumab-based Therapy. Clinical Lymphoma Myeloma and Leukemia, 21(8), e674–e677. https://doi.org/10.1016/j.clml.2021.04.011
Authors:
Alexander Coltoff
Suzanne Lentzsch
Divaya Bhutani
Andrew Bomback
Shayan Shirazian
Affiliated Authors:
Alexander Coltoff
Suzanne Lentzsch
Divaya Bhutani
Andrew Bomback
Shayan Shirazian
Columbia Affiliation:
Author Keywords:
myeloma
cd38
targeted therapy
plasma cells
c3 glomerulopathy monoclonal gammopathy of renal significance
elink
Publication Type:
Article
Unique ID:
10.1016/j.clml.2021.04.011
PMID:
34023209
DOI:
10.1016/j.clml.2021.04.011
Journal:
Clinical Lymphoma, Myeloma and Leukemia
Publication Date:
Data Source:
Web of Science
Source Link:
View Web of Science Record

Record Created: